https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Functional Additives Medical Devices Application Bulletin.pdf
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates and ready-to-use formulations REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS DRUG DELIVERY DEVICES SYRINGES & NEEDLES DIAGNOSTICS CATHETERS Clarifying PP Sorbitol-free for transparent applications with reduced migration and improved thermal stability Lubricant— permanent/ non-migrating Fast acting reduction in friction for wide variety of polymers such as PP, ABS, POM, PC Protection from UV in transparent applications for PP, PE, PETG, COP UV blocking in 290-450nm with no impact on clarity; can be combined with colors (e.g., amber) Antistatic ready-to- use solution for PP, ABS, PC/ABS Permanent/non-migrating; fast decay time independent of % relative humidity Gamma/e-beam sterilization protection of the polymer Preserving the properties of PP and COC/COP; reduction in yellowing using Color Compensation Technology (CCT) Reduced material consumption/cycle time—nucleation Fast acting new generation nucleant for PE and PP; improved thermal and mechanical properties allows wall thinning; reduction of tolerance/dimensional problems between different colors Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser for PE,PP, ABS, PC, POM Antioxidants for PE, PP, TPE Thermal protection during converting/downstream sterilization Brand protection/ anticounterfeit Covert and non-covert systems Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Functional Additives Pharma Pkg Application Bulletin.pdf
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates or formulations REGULATORY SUPPORT • Pre-tested raw materials: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS EBM/IBM CONTAINERS CLOSURES FILM COMBINATION DEVICES Clarifying PP Sorbitol-free—possibilities in packaging ocular solutions Slip/torque reduction Slip for PE, PP films, processing aid, torque reduction for closures Protection from UV in transparent packaging for PP, PE, PETG, COP UV blocking in 290–450nm with no impact on clarity Antistatic ready-to-use solution for PE films e.g. for API handling Permanent/non-migrating; fast decay time independent of % relative humidity Antistatic masterbatch for PE films Cost effective, long-lasting, migrating type but with biological evaluation Gamma/e-beam sterilization protection of the polymer Preserving the properties of PP and COC/COP.
Reduction in yellowing using Color Compensation Technology (CCT) Reduced material consumption/cycle time/improved properties—nucleation Fast acting new generation nucleant for PE and PP; improved dimensional stability, thermal and mechanical properties Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser Antiblock for PE/PP film Non-migrating additive system maintaining high gloss and printability Antioxidants for PE, PP, TPE Thermal protection during converting/ downstream sterilization Brand protection/ anticounterfeit Range of covert and non-covert systems Volatiles/odor absorber for PE/PP Physical absorption of a wide range of molecules responsible for odor, VOC and potential extractables/ leachables in plastics Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2021-05/complet-lft-office-furniture-task-chair.pdf
Office Furniture Task Chair LEADING OFFICE FURNITURE OEM T A S K C H A I R • Stiff yet extremely tough all-composite solution • Reduce part count by replacing mechanical tilt controls • Cost-effective material • Exceptional fatigue endurance to withstand million cycle deflection test • Enabled novel design by combining long glass fiber and unidirectional tape to meet performance and mass market cost targets • Formulated custom nylon material with minimal conditioned performance loss and smooth, fiber-free surface finish • Provided technical support during two-year product development cycle Complēt™ Long Glass Fiber PA66 Composite and Overmolded Unidirectional Tape Inserts KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-04/versaflex-hc-bt218-biopharmaceutical-tubing-case-study.pdf
MEDICAL TUBING EXTRUDER B I O P H A R M A C E U T I C A L T U B I N G • Low leachables & extractables • Great tensile performance and kink resistance • Good thermal weldability • Excellent clarity and medical blue tint • ISO 10993-4 & 5, USP Class VI & Animal Derivative Free (ADF) • Supplied drop-in material replacement to overcome supply constraints of incumbent TPE • Offered a lower extractable profile than comparable materials in the market • Enabled easy material transition without changes in tooling or thermal welding machine settings • Formulated solution with proprietary additives to provide clarity and prevent yellowing after sterilization Versaflex™ HC BT218 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2025-02/ColorMatrix LQ_Corrugated sheet _Case study snapshot.pdf
U-PVC WALL CEILING PRODUCER C O R R U G A T E D S H E E T • Achieved the beige color target with a uniform coloring process, ensuring a high- quality sheet appearance • Adjusted color strength in sheet production using online controls at the pump controller • Maintained a clean operation by eliminating powdery pigments in the workplace ColorMatrix Liquid Color Concentrates WHY AVIENT AVIENT SOLUTION PRODUCTIVITY + SAFETY LIQUID COLOR CONCENTRATES AND DOSING | AVIENTLEARN MORE • Reduces particulates from TiO2 bulk pigment use in the workplace • Color consistency and good surface finish • Maintain good mechanical properties and shore hardness of the extruded sheet • Compliance with heavy metal-free and RoHS regulations KEY REQUIREMENTS Copyright © 2025, Avient Corporation.
https://www.avient.com/sites/default/files/2022-02/Pipe and Conduit OEM App Snapshot final.pdf
continuous lifting of 55 lbs. bags) and eliminate transport of raw material up stairs or on to mezzanine to reduce potential for injuries during material handling • Provide a dust-free raw material handling and manufacturing environment • Alleviate employee health concerns by providing a cleaner production floor and lower levels of airborne TiO2 dust • Maintain an OSHA compliant facility • Automated a raw material handling solution that included no lifting, cutting, or tearing of raw material packaging • Eliminated fine TiO2 and pigment-related particles, providing cleaner air in manufacturing areas • Provided a safe and sustainable environment by helping reduce workplace dust exposure • Enabled employee redeployment to other activities, optimizing use of labor ColorMatrix™ Liquid Colorant and Dosing Equipment KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/investor-center/news/avient-announces-record-fourth-quarter-and-full-year-2021-results
and the investments we have made in sustainability, advancing diversity and inclusion, and workplace flexibility,"
We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.
The non-GAAP financial measures include: adjusted EPS, adjusted operating income, free cash flow, adjusted EBITDA and net debt.
https://www.avient.com/sites/default/files/resources/AquaMix-_Fact_Sheet__72831-B_%25281%2529.pdf
Our manufacturing facility also offers technologically advanced product development services.
Our manufacturing facility also offers technologically advanced product development services.
A line of casein-free dispersions is also available. 17 in 11 in 17.25 in 11.25 in CMYK P1PC-011AquamixFactSheet2.indd REMAY 72831-B Zig trim: 17.000" x 11.000" bleed: .125" Digital/IAM QC˛______ ______ Client˛_____ _____ Date ____/____/____ Proof No.4______ 25 50 100 25 50 100 25 2 2 50 100 25 2 2 50 100 Asset No. 72831-B
https://www.avient.com/sites/default/files/2024-03/2024 Proxy Statement_March.pdf
Safety and Health The top priority at Avient is the safety and health of our associates, and our ultimate goal is to operate injury free.
In some instances the full Board also receives the update.
Key 2023 Company Performance Results and Return to Shareholders.
https://www.avient.com/sites/default/files/resources/POL%2520BofA%2520Basic%2520Materials%2520IR%2520Presentation%2520w%2520non-GAAP%252012%252011%25202013.pdf
• We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.
Use of Non-GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 All time high of $34.47 December 9th, 2013 • 16 consecutive quarters of double digit EPS growth • 42% CAGR adjusted EPS expansion 2006-2012 • YTD stock price has increased 63% versus 27% growth in the S&P • More than six fold increase in market cap: $0.5b $3.3b Strategy and Execution Drive Results Page 4 The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target Ad ju st ed E ar ni ng s P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 6 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 63% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 YTD 2013 2015 % o f O pe ra tin g In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $153M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 YTD 2013 2015 Where we were Where we are Organic Consolidated Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.8% 12.8% 12 – 16% Global Specialty Engineered Materials 1.1% 10.8% 8.9% 12 – 16% Designed Structures & Solutions — — 5.0% 8 – 10% Performance Products & Solutions 5.5% 8.0% 8.2% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 63% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 28% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 44.0% 2006 Q3 2013 $20.3 $46.6 2006 TTM Q3'13 14.3% 31.0% 2006 Q3 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 9 We are Experts in Polymer Science and Formulation Polymer Science Formulation Chemistry Processing Inputs Base Resins Additives Modifiers Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services Marketplace Demands Performance Requirements Value Drivers Page 10 Positioned for Strong Growth 2015 Target Rev: $5B Adj.